Orecchia, P., Conte, R., Balza, E., Pietra, G., Mingari, M. C., & Carnemolla, B. (2015). Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts. Oncotarget.

Orecchia, Paola, Romana Conte, Enrica Balza, Gabriella Pietra, Maria Cristina Mingari, and Barbara Carnemolla. "Targeting Syndecan-1, a Molecule Implicated in the Process of Vasculogenic Mimicry, Enhances the Therapeutic Efficacy of the L19-IL2 Immunocytokine in Human Melanoma Xenografts." Oncotarget 2015.

Orecchia, Paola, et al. "Targeting Syndecan-1, a Molecule Implicated in the Process of Vasculogenic Mimicry, Enhances the Therapeutic Efficacy of the L19-IL2 Immunocytokine in Human Melanoma Xenografts." Oncotarget 2015.